mechlorethamine has been researched along with Canine Diseases in 7 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle." | 7.81 | Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015) |
| "Forty-one dogs with resistant lymphoma were treated with a modified MOPP (mechlorethamine, vincristine, procarbazine and prednisone) protocol (MPP [mechlorethamine, procarbazine and prednisone] administered on a 21-day cycle, shortened from the 28-day MOPP cycle)." | 7.75 | Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs. ( Childress, MO; Gieger, TL; Hume, KR; Keys, DA; Kosarek, CE; LeRoy, BE; Northrup, NC; Saba, CF; Wall, TM, 2009) |
| "Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle." | 3.81 | Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015) |
| "Forty-one dogs with resistant lymphoma were treated with a modified MOPP (mechlorethamine, vincristine, procarbazine and prednisone) protocol (MPP [mechlorethamine, procarbazine and prednisone] administered on a 21-day cycle, shortened from the 28-day MOPP cycle)." | 3.75 | Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs. ( Childress, MO; Gieger, TL; Hume, KR; Keys, DA; Kosarek, CE; LeRoy, BE; Northrup, NC; Saba, CF; Wall, TM, 2009) |
| "Dogs with malignant lymphoma were given chemotherapy consisting of nitrogen mustard, vincristine sulfate, prednisone, L-asparaginase, and 6-mercaptopurine (MOPA-6) for 14 days." | 3.67 | Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation. ( Appelbaum, FR; Deeg, HJ; Graham, TC; Hackman, RC; Storb, RC; Weiden, PL, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Zimmerman, K | 1 |
| Walsh, KA | 1 |
| Ferrari, JT | 1 |
| Keuler, NS | 1 |
| Atherton, MJ | 1 |
| Lenz, JA | 1 |
| Back, AR | 1 |
| Schleis, SE | 1 |
| Smrkovski, OA | 1 |
| Lee, J | 1 |
| Smith, AN | 1 |
| Phillips, JC | 1 |
| Northrup, NC | 1 |
| Gieger, TL | 1 |
| Kosarek, CE | 1 |
| Saba, CF | 1 |
| LeRoy, BE | 1 |
| Wall, TM | 1 |
| Hume, KR | 1 |
| Childress, MO | 1 |
| Keys, DA | 1 |
| Rassnick, KM | 1 |
| Bailey, DB | 1 |
| Malone, EK | 1 |
| Intile, JL | 1 |
| Kiselow, MA | 1 |
| Flory, AB | 1 |
| Barlow, LL | 1 |
| Balkman, CE | 1 |
| Barnard, SM | 1 |
| Waite, AH | 1 |
| McKeever, PJ | 1 |
| Grindem, CB | 1 |
| Stevens, JB | 1 |
| Osborne, CA | 1 |
| Deeg, HJ | 1 |
| Appelbaum, FR | 1 |
| Weiden, PL | 1 |
| Hackman, RC | 1 |
| Graham, TC | 1 |
| Storb, RC | 1 |
| Whitney, MS | 1 |
| Boon, GD | 1 |
| Rebar, AH | 1 |
| Ford, RB | 1 |
1 trial available for mechlorethamine and Canine Diseases
| Article | Year |
|---|---|
Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Cyclophosphamide; Dog Diseases; | 2010 |
6 other studies available for mechlorethamine and Canine Diseases
| Article | Year |
|---|---|
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Doxorubicin; Lymphoma; | 2023 |
Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lymphoma; Lymph | 2015 |
Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; | 2009 |
Canine cutaneous lymphoma.
Topics: Animals; Cyclophosphamide; Dog Diseases; Dogs; Female; Lymphocytes; Male; Mechlorethamine; Mycosis F | 1982 |
Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; | 1985 |
Evaluation of a spectrophotometric method for canine serum lipase determination.
Topics: Acute Disease; Animals; Clinical Enzyme Tests; Dithionitrobenzoic Acid; Dog Diseases; Dogs; Evaluati | 1986 |